| abstract |
The invention relates to bicyclic substituted cyclohexylamines of the formula wherein the substituents are as defined in the specification and to their pharmaceutically acceptable salts. The compounds are antagonists of the NMDA receptor channel complexes and are useful for the treatment of cerebrovascular diseases, e.g., cerebral ischemia, heart arrest, stroke, and Parkinson ' s disease. |